| Radiopharm Theranostics Limited | 51M | US$671M | 378.3% |
| Verastem, Inc. | 3.35M | US$12.8M | 7.2% |
| Evolus, Inc. Common Stock | 1.59M | US$11M | 6.2% |
| Tenax Therapeutics, Inc. | 660K | US$9.6M | 5.4% |
| Nektar Therapeutics | 121K | US$8.42M | 4.8% |
| Adma Biologics Inc | 740K | US$6.19M | 3.5% |
| Camp4 Therapeutics Corporation | 1.39M | US$6.07M | 3.4% |
| Eloxx Pharmaceuticals, Inc. | 397K | US$5.51M | 3.1% |
| Indivior Pharmaceuticals, Inc. | 100K | US$4.1M | 2.3% |
| Corbus Pharmaceuticals Holdings, Inc. | 425K | US$3.99M | 2.2% |
| Satellos Bioscience Inc | 492K | US$3.72M | 2.1% |
| Zevra Therapeutics, Inc. | 259K | US$3.71M | 2.1% |
| Abeona Therapeutics Inc. | 557K | US$3.44M | 1.9% |
| Edesa Biotech, Inc. | 456K | US$3.19M | 1.8% |
| Cabaletta Bio, Inc. | 917K | US$2.85M | 1.6% |
| An2 Therapeutics, Inc. | 552K | US$2.67M | 1.5% |
| Xilio Therapeutics, Inc. | 226K | US$2.17M | 1.2% |
| Adicet Bio, Inc. | 246K | US$2.12M | 1.2% |
| Tela Bio, Inc. | 2.66M | US$2M | 1.1% |
| Aytu Biopharma, Inc. | 913K | US$1.96M | 1.1% |
| Curis, Inc. | 3.31M | US$1.73M | 0.98% |
| Spruce Biosciences, Inc. | 28,795 | US$1.55M | 0.88% |
| Pasithea Therapeutics Corp. | 2.2M | US$1.13M | 0.64% |
| Pulmonx Corporation | 815K | US$1.06M | 0.60% |
| X4 Pharmaceuticals, Inc. | 225K | US$1.05M | 0.59% |
| In8bio, Inc. | 695K | US$980K | 0.55% |
| Maxcyte, Inc. | 752K | US$924K | 0.52% |
| Phathom Pharmaceuticals, Inc. | 85,010 | US$922K | 0.52% |
| Azitra Inc | 5.29M | US$887K | 0.50% |
| Connect Biopharma Holdings Limited | 364K | US$867K | 0.49% |
| Cybin, Inc. | 129K | US$855K | 0.48% |
| Ultragenyx Pharmaceutical Inc. | 25,000 | US$835K | 0.47% |
| Inhibikase Therapeutics, Inc. | 396K | US$804K | 0.45% |
| Zentalis Pharmaceuticals, Inc. | 162K | US$784K | 0.44% |
| Cytomx Therapeutics, Inc. | 205K | US$769K | 0.43% |
| Nuvectis Pharma, Inc. | 40,000 | US$736K | 0.41% |
| Crescent Biopharma, Inc. | 40,000 | US$720K | 0.41% |
| Pmv Pharmaceuticals, Inc. | 536K | US$718K | 0.41% |
| Oruka Therapeutics, Inc. | 7,500 | US$714K | 0.40% |
| Onkure Therapeutics, Inc. | 131K | US$596K | 0.34% |
| Nervgen Pharma Corp. | 272K | US$560K | 0.32% |
| Calcimedica, Inc. | 622K | US$545K | 0.31% |
| Arvinas, Inc. | 60,000 | US$499K | 0.28% |
| Bioage Labs, Inc. | 20,000 | US$490K | 0.28% |
| Opus Genetics, Inc. | 101K | US$414K | 0.23% |
| Qt Imaging Holdings, Inc. | 100K | US$407K | 0.23% |
| Boundless Bio, Inc. | 155K | US$386K | 0.22% |
| Sintx Technologies, Inc. | 209K | US$333K | 0.19% |
| Cellectar Biosciences, Inc. | 105K | US$291K | 0.16% |
| Eupraxia Pharmaceuticals, Inc. | 43,491 | US$287K | 0.16% |
| Sab Biotherapeutics, Inc. | 73,271 | US$286K | 0.16% |
| Senseonics Holdings, Inc. | 48,680 | US$277K | 0.16% |
| Pliant Therapeutics, Inc. | 231K | US$263K | 0.15% |
| Codexis, Inc. | 110K | US$248K | 0.14% |
| Precision Optics Corporation, Inc. | 46,390 | US$237K | 0.13% |
| Upstream Bio, Inc. | 33,432 | US$231K | 0.13% |
| Rein Therapeutics, Inc. | 218K | US$227K | 0.13% |
| Heron Therapeutics, Inc. | 491K | US$209K | 0.12% |
| Cns Pharmaceuticals, Inc. | 41,573 | US$199K | 0.11% |
| Humacyte, Inc. | 231K | US$181K | 0.10% |
| Kalaris Therapeutics, Inc. | 30,122 | US$123K | 0.07% |
| Processa Pharmaceuticals, Inc. | 55,000 | US$106K | 0.06% |
| Bioatla, Inc. | 16,432 | US$68,028 | 0.04% |
| Ovid Therapeutics Inc. | 21,300 | US$57,297 | 0.03% |
| Candel Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Eledon Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Establishment Labs Holdings Inc. | 0 | US$0 | 0.00% |
| Janux Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Mannkind Corporation | 0 | US$0 | 0.00% |
| Neumora Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Omniab, Inc. | 0 | US$0 | 0.00% |
| Si-bone, Inc. | 0 | US$0 | 0.00% |
| Surrozen, Inc. | 0 | US$0 | 0.00% |
| Verrica Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Xeris Biopharma Holdings, Inc. | 0 | US$0 | 0.00% |
| Xoma Royalty Corporation | 0 | US$0 | 0.00% |